A Systematic Review and Meta-analysis of the Accuracy of SARS-COV-2 IGM and IGG Tests in Individuals with COVID-19

Overview

Journal J Clin Virol

Specialty Microbiology

Date 2022 Mar 4

PMID 35245882

Authors

Ana Cristina Lacerda Macedo

Gabriele da Silveira Prestes

Tamy Colonetti

Ana Claudia Rodrigues Candido

Maria Laura Rodrigues Uggioni

Ariane Cruz Gomes

Fabio Rosa Silva

Luciane Bisognin Ceretta

Antonio Jose Grande

Maria Ines da Rosa

Affiliations

Soon will be listed here.

Abstract

Introduction: Active SARS-CoV-2 infection is confirmed mainly through the detection of viral nucleic acid via the reverse transcriptase polymerase chain reaction (RT-PCR) technique. Methods to assess humoral responses contribute to the monitoring of the disease and confirmation of exposure to the virus.

Objective: To evaluate the accuracy of tests for IgM and IgG antibodies for SARS-CoV-2 infection confirmed by RT-PCR and utility as complementary data for immunosurveillance.

Methods: Literature research was performed by searching the terms "COVID-19", "COVID-19 diagnostic testing" and "test" in the databases MEDLINE, EMBASE, Cochrane Library, Web of Science and Cumulative Index to Nursing and Allied Health Literature to search for potentially eligible observational studies without language restrictions published up to September 2020.

Results: The pooled sensitivity and specificity, regardless of collection moment, was 80.0% (CI 95% 72.0-86.0) and 97.0% (CI 95% 94.0-98.0) for "IgM and/or IgG", respectively. Serology considering immunoglobulins M and G together had a high accuracy performance on "fifteenth day and after": sensitivity and specificity was 91.0% (CI 95% 85.0-94.0) and 98.0% (CI 95% 95.0-99.0) respectively, DOR 461 and AUC 0.98.

Conclusion: This study shows that serology is a group of tests with high accuracy, mainly following the second week after infection.

Citing Articles

Development and Evaluation of In-House ELISAs for the Detection of SARS-CoV-2-Specific Antibodies in COVID-19 Patients in Sri Lanka.

Pathirana S, Deepachandi B, Gunasekara P, Fernando N, Perera I, Gangani D Int J Microbiol. 2024; 2024:1331067.

PMID: 39346702 PMC: 11427722. DOI: 10.1155/2024/1331067.

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.

Schilling W, Mukaka M, Callery J, Llewelyn M, Cruz C, Dhorda M PLoS Med. 2024; 21(9):e1004428.

PMID: 39264960 PMC: 11392261. DOI: 10.1371/journal.pmed.1004428.

Testing for SARS-CoV-2: lessons learned and current use cases.

Theel E, Kirby J, Pollock N Clin Microbiol Rev. 2024; 37(2):e0007223.

PMID: 38488364 PMC: 11237512. DOI: 10.1128/cmr.00072-23.

Performance of Three Anti-SARS-CoV-2 Anti-S and One Anti-N Immunoassays for the Monitoring of Immune Status and Vaccine Response.

Zhang Y, Kumanovics A, Wiencek J, Melanson S, Love T, Wu A Viruses. 2024; 16(2.

PMID: 38400067 PMC: 10891747. DOI: 10.3390/v16020292.

Comparison of the conventional tube and erythrocyte-magnetized technology in titration of red blood cell alloantibodies.

He X, Yan H, Wang C, Duan X, Qiao J, Guo X World J Biol Chem. 2023; 14(3):62-71.

PMID: 37273684 PMC: 10236968. DOI: 10.4331/wjbc.v14.i3.62.

References

Herroelen P, Martens G, De Smet D, Swaerts K, Decavele A . Humoral Immune Response to SARS-CoV-2. Am J Clin Pathol. 2020; 154(5):610-619. PMC: 7454302. DOI: 10.1093/ajcp/aqaa140. View

Phipps W, Sorelle J, Li Q, Mahimainathan L, Araj E, Markantonis J . SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity. Am J Clin Pathol. 2020; 154(4):459-465. PMC: 7454292. DOI: 10.1093/ajcp/aqaa123. View

Cassaniti I, Novazzi F, Giardina F, Salinaro F, Sachs M, Perlini S . Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department. J Med Virol. 2020; 92(10):1724-1727. PMC: 7228409. DOI: 10.1002/jmv.25800. View

Pieri M, Ciotti M, Carlozzi N, Frassanito M, Meloni A, Cistera A . SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection. Clin Chim Acta. 2020; 511:28-32. PMC: 7834570. DOI: 10.1016/j.cca.2020.09.033. View

Tan C, Chia W, Qin X, Liu P, Chen M, Tiu C . A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction. Nat Biotechnol. 2020; 38(9):1073-1078. DOI: 10.1038/s41587-020-0631-z. View

Suhandynata R, Hoffman M, Kelner M, McLawhon R, Reed S, Fitzgerald R . Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19. J Appl Lab Med. 2020; 5(5):908-920. PMC: 7313967. DOI: 10.1093/jalm/jfaa079. View

Infantino M, Damiani A, Li Gobbi F, Grossi V, Lari B, Macchia D . Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives. Isr Med Assoc J. 2020; 22(4):203-210. View

Pegoraro M, Militello V, Salvagno G, Gaino S, Bassi A, Caloi C . Evaluation of three immunochromatographic tests in COVID-19 serologic diagnosis and their clinical usefulness. Eur J Clin Microbiol Infect Dis. 2020; 40(4):897-900. PMC: 7572234. DOI: 10.1007/s10096-020-04040-1. View

Yassine H, Al-Jighefee H, Al-Sadeq D, Dargham S, Younes S, Shurrab F . Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies. Int J Infect Dis. 2020; 102:181-187. PMC: 7590641. DOI: 10.1016/j.ijid.2020.10.042. View

10.

Pfluger L, Bannasch J, Brehm T, Pfefferle S, Hoffmann A, Norz D . Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients. J Clin Virol. 2020; 130:104549. PMC: 7367003. DOI: 10.1016/j.jcv.2020.104549. View

11.

Petherick A . Developing antibody tests for SARS-CoV-2. Lancet. 2020; 395(10230):1101-1102. PMC: 7270070. DOI: 10.1016/S0140-6736(20)30788-1. View

12.

Rongqing Z, Li M, Song H, Chen J, Ren W, Feng Y . Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies as a Serologic Marker of Infection in Patients With Coronavirus Disease 2019. Clin Infect Dis. 2020; 71(16):2066-2072. PMC: 7197602. DOI: 10.1093/cid/ciaa523. View

13.

Andrey D, Cohen P, Meyer B, Torriani G, Yerly S, Mazza L . Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test. Eur J Clin Invest. 2020; 50(10):e13357. PMC: 7404380. DOI: 10.1111/eci.13357. View

14.

Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A . Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006; 6:31. PMC: 1552081. DOI: 10.1186/1471-2288-6-31. View

15.

Wang D, Mou Z, Zhai J, Zong H, Zhao X . [Application of Stata software to test heterogeneity in meta-analysis method]. Zhonghua Liu Xing Bing Xue Za Zhi. 2008; 29(7):726-9. View

16.

Jin Y, Wang M, Zuo Z, Fan C, Ye F, Cai Z . Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019. Int J Infect Dis. 2020; 94:49-52. PMC: 7194885. DOI: 10.1016/j.ijid.2020.03.065. View

17.

Tehrani Z, Saadat S, Saleh E, Ouyang X, Constantine N, DeVico A . Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays. PLoS One. 2020; 15(11):e0237828. PMC: 7605638. DOI: 10.1371/journal.pone.0237828. View

18.

Deeks J, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S . Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev. 2020; 6:CD013652. PMC: 7387103. DOI: 10.1002/14651858.CD013652. View

19.

Charlton C, Kanji J, Johal K, Bailey A, Plitt S, MacDonald C . Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies. J Clin Microbiol. 2020; 58(10). PMC: 7512179. DOI: 10.1128/JCM.01361-20. View

20.

Wang Q, Du Q, Guo B, Mu D, Lu X, Ma Q . A Method To Prevent SARS-CoV-2 IgM False Positives in Gold Immunochromatography and Enzyme-Linked Immunosorbent Assays. J Clin Microbiol. 2020; 58(6). PMC: 7269408. DOI: 10.1128/JCM.00375-20. View